| Outgoing Relation(s) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) has role insulin-like growth factor receptor 1 antagonist (CHEBI:75252) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a aminopyrimidine (CHEBI:38338) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a aminoquinoline (CHEBI:36709) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a monomethoxybenzene (CHEBI:25235) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a morpholines (CHEBI:38785) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a secondary amino compound (CHEBI:50995) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a tertiary amino compound (CHEBI:50996) |